BRPI0417182A - composto e/ou os enantiÈmeros, diastereoisÈmeros e sais farmaceuticamente aceitáveis do mesmo, uso do mesmo, e, composição farmacêutica - Google Patents

composto e/ou os enantiÈmeros, diastereoisÈmeros e sais farmaceuticamente aceitáveis do mesmo, uso do mesmo, e, composição farmacêutica

Info

Publication number
BRPI0417182A
BRPI0417182A BRPI0417182-9A BRPI0417182A BRPI0417182A BR PI0417182 A BRPI0417182 A BR PI0417182A BR PI0417182 A BRPI0417182 A BR PI0417182A BR PI0417182 A BRPI0417182 A BR PI0417182A
Authority
BR
Brazil
Prior art keywords
pharmaceutically acceptable
salts
diastereoisomers
compound
pharmaceutical composition
Prior art date
Application number
BRPI0417182-9A
Other languages
English (en)
Inventor
Piero Del Soldato
Francesca Benedini
Ennio Ongini
Original Assignee
Nicox Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nicox Sa filed Critical Nicox Sa
Publication of BRPI0417182A publication Critical patent/BRPI0417182A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/101,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

"COMPOSTO E/OU OS ENANTIÈMEROS , DIASTEREOISÈMEROS E SAIS FARMACEUTICAMENTE ACEITáVEIS DO MESMO, USO DO MESMO, E, COMPOSIçãO FARMACêUTICA". A presente invenção refere-se aos nitro-óxi-derivados de bloqueadores adrenérgicos-<225> de fórmula geral (I): A-(Y-ONO~ 2~)~ 5~ e aos enantiómeros e diastereoisómeros e sais farmaceuticamente aceitáveis dos mesmo, às composições farmacêuticas contendo-os e ao uso deles para o tratamento de hipertensão, doenças cardiovasculares, glaucoma, dor de cabeça enxaqueca e doenças vasculares.
BRPI0417182-9A 2003-12-02 2004-12-01 composto e/ou os enantiÈmeros, diastereoisÈmeros e sais farmaceuticamente aceitáveis do mesmo, uso do mesmo, e, composição farmacêutica BRPI0417182A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03104485 2003-12-02
PCT/EP2004/013682 WO2005054218A1 (en) 2003-12-02 2004-12-01 Nitrooxyderivatives of antihypertensive drugs

Publications (1)

Publication Number Publication Date
BRPI0417182A true BRPI0417182A (pt) 2007-03-06

Family

ID=34639310

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0417182-9A BRPI0417182A (pt) 2003-12-02 2004-12-01 composto e/ou os enantiÈmeros, diastereoisÈmeros e sais farmaceuticamente aceitáveis do mesmo, uso do mesmo, e, composição farmacêutica

Country Status (21)

Country Link
US (1) US20070060586A1 (pt)
EP (1) EP1748994B1 (pt)
JP (1) JP2007513113A (pt)
KR (1) KR20060120164A (pt)
CN (1) CN1906182A (pt)
AP (1) AP2006003622A0 (pt)
AR (1) AR047264A1 (pt)
AT (1) ATE423107T1 (pt)
AU (1) AU2004295105A1 (pt)
BR (1) BRPI0417182A (pt)
CA (1) CA2548127A1 (pt)
DE (1) DE602004019579D1 (pt)
EA (1) EA200600891A1 (pt)
EC (1) ECSP066590A (pt)
ES (1) ES2320002T3 (pt)
IL (1) IL176061A0 (pt)
MA (1) MA28224A1 (pt)
NO (1) NO20062527L (pt)
TN (1) TNSN06151A1 (pt)
WO (1) WO2005054218A1 (pt)
ZA (1) ZA200604463B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002087508A2 (en) 2001-05-02 2002-11-07 Nitromed, Inc. Nitrosated and nitrosylated nebivolol and its metabolites, compositions and methods of use
EP1981852A1 (en) 2006-02-06 2008-10-22 NicOx S.A. Nitrooxy-comprising derivatives of apraclonidine and brimodnidine as al pha2 -adrenergic receptor agonists
WO2007090733A1 (en) * 2006-02-06 2007-08-16 Nicox S.A. Nitrooxy derivatives suitable as alpha2 adrenergic receptor agonists
AU2021241591A1 (en) 2020-03-24 2022-10-20 Michael W. BURNET Anti-infective and anti-viral compounds and compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3443998A1 (de) * 1984-12-01 1986-06-05 Boehringer Mannheim Gmbh, 6800 Mannheim Amino-propanol-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel sowie zwischenprodukte
ES2065291B1 (es) * 1993-07-30 1995-10-01 Prodesfarma Sa "nitrato esteres de 1-ariloxi-3-alquilamino-2-propanoles, utilizacion y composicion farmaceutica correspondiente"
IT1295694B1 (it) * 1996-11-14 1999-05-27 Nicox Sa Nitrossi derivati per la preparazione di medicamenti ad attivita antitrombinica
IT1311923B1 (it) * 1999-04-13 2002-03-20 Nicox Sa Composti farmaceutici.
IT1314184B1 (it) * 1999-08-12 2002-12-06 Nicox Sa Composizioni farmaceutiche per la terapia di condizioni di stressossidativo

Also Published As

Publication number Publication date
AP2006003622A0 (en) 2006-06-30
NO20062527L (no) 2006-06-30
EP1748994A1 (en) 2007-02-07
CA2548127A1 (en) 2005-06-16
DE602004019579D1 (de) 2009-04-02
AR047264A1 (es) 2006-01-11
ATE423107T1 (de) 2009-03-15
JP2007513113A (ja) 2007-05-24
MA28224A1 (fr) 2006-10-02
TNSN06151A1 (en) 2007-11-15
CN1906182A (zh) 2007-01-31
ZA200604463B (en) 2007-04-25
ES2320002T3 (es) 2009-05-18
EA200600891A1 (ru) 2006-10-27
US20070060586A1 (en) 2007-03-15
ECSP066590A (es) 2006-10-17
IL176061A0 (en) 2006-10-05
EP1748994B1 (en) 2009-02-18
AU2004295105A1 (en) 2005-06-16
KR20060120164A (ko) 2006-11-24
WO2005054218A1 (en) 2005-06-16

Similar Documents

Publication Publication Date Title
SE0302760D0 (sv) New compounds
BRPI0418102A (pt) derivados de quinolina
BR0212378A (pt) Inibidores de 17beta-hidroxiesteróide desidrogenase tipo 3 para o tratamento de doenças dependentes de androgênio
BRPI0308495B8 (pt) composto piridinoila útil para a ativação de receptores 5-ht1f, formulação farmacêutica, e, uso de um composto
NO20072978L (no) Nye betuinderivater, preparat derav og anvendelse derav
NO20033181L (no) Substituerte alkylaminderivater og fremgangsmåter for anvendelse
EA200970585A1 (ru) Бензамидные производные как агонисты ер-рецепторов
BR0316081A (pt) Derivados de 2-piridona como inibidores de elastase de neutrófilo
BRPI0418245B8 (pt) composto derivado de nitróxi de prostaglandina, processo para preparar dito composto, composição farmacêutica compreendendo dito composto e usos destes
EA201001669A1 (ru) Замещенные пиримидин-5-карбоксамиды 281
CY1111693T1 (el) Αντιιικοι παραγοντες
BRPI0715579A2 (pt) &#34;composto, composição farmacêutica e uso de um composto&#34;
BRPI0601282A (pt) composição, e método de modificar a formação de hidrato de gás
BRPI0508107A (pt) derivados de indazol e composições farmacêuticas contendo os mesmos
SE0401971D0 (sv) Piperidne derivatives
BRPI0415759A (pt) compostos de pirimidin-4-il-3,4-tiona e uso dos mesmos na terapia
ATE440833T1 (de) Antithrombotische diamide
ATE307810T1 (de) Imidazol-2-carbonsäureamid derivate als raf- kinase-inhibitoren
BR0210538A (pt) Derivados de 5-halotriptamina usados como ligantes dos receptores de serotonina 5-ht6 e/ou 5-ht7
BR0315143A (pt) Composto, processo para a preparação dos (r) e (s) - enanciÈmeros individuais ou misturas de enanciÈmeros e sais farmaceuticamente aceitáveis de um composto, composição farmacêutica, e, uso de um composto
MX2007004740A (es) Derivados de 2-amido-4-feniltiazol, su preparacion y su aplicacion en terapeutica.
BRPI0409110A (pt) derivados de 4-(4-heterociclilalcoxi)fenil-1-(heterociclil-carboni l)piridina e compostos relacionados como antagonistas de histamina h3 para o tratamento de doenças neurológicas tais como alzheimer
ATE372995T1 (de) Benzo(b)(1,4)dioxepinderivate
BRPI0409465A (pt) derivados de carboxamida como agentes antidiabéticos
ATE523498T1 (de) Hiv-inhibierende 2-(4- cyanophenylamino)pyrimidinderivate

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012.